Model Systems for Fragile X Pre-Mutation and Primary Ovarian Insufficiency (FX-POI) (R21)

The summary for the Model Systems for Fragile X Pre-Mutation and Primary Ovarian Insufficiency (FX-POI) (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Model Systems for Fragile X Pre-Mutation and Primary Ovarian Insufficiency (FX-POI) (R21)
	CFDA Number:	93.865
	CFDA Description:	Child Health and Human Development Extramural Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PAR-11-137
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Mar 09, 2011
	Creation Date:	Mar 09, 2011
	Original Closing Date for Applications:	Jun 01, 2012
	Current Closing Date for Applications:	Jun 01, 2012
	Archive Date:	Jul 02, 2012
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	200,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are allowed.
Grant Description: The purpose of this funding opportunity announcement (FOA) is to stimulate the development of new model systems and/or the thorough characterization of the ovarian phenotype of existing models of fragile X associated premature ovarian insufficiency (FX-POI). New and well-characterized models of FX-POI will help us to answer fundamental questions about the role of the FMR1 repeat expansion in ovarian function and reproductive aging, and allow the field to advance into evidence based clinical research on fragile X pre-mutation carriers who are at risk for POI.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/par-11-137.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]; • Rehabilitation Research Career Development Programs (K12); • Pediatric Scientist Development Program (PSDP) [K12]; • Translational Research in Pediatric and Obstetric Pharmacology (R21); • Translational Research in Pediatric and Obstetric Pharmacology (R01); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Stud...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Preclinical Stud...; • REPRODUCTIVE GENETICS AND EPIGENETICS; • DEVELOPMENTAL MECHANISMS OF HUMAN STRUCTURAL BIRTH DEFECTS; • ENDOMETRIAL CELL FUNCTION